Back to VANGUARD GROUP INC VANGUARD GROUP INC

NVCTNVCT
6 quarters

Position history for VANGUARD GROUP INCVANGUARD GROUP INC's holdings in NUVECTIS PHARMA INC

VANGUARD GROUP INC holds 845,502 shares of NVCT (NUVECTIS PHARMA INC), worth $6.4M as of 2025-Q4. The position was increased (+21.0% shares). NVCT represents 0.0% of VANGUARD GROUP INC's portfolio.

Current Value

$6.4M

Current Shares

845,502

Total Value Change

+$4.5M

Total Shares Change

+544,364

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Increased
845,502
+21.0%
$6.4M0.0%$7.38
33
2025-Q3
Increased
698,708
+4.8%
$4.2M0.0%$5.92
28
2025-Q2
Increased
666,805
+42.7%
$5M0.0%$7.55
36
2025-Q1
Increased
467,419
+43.7%
$4.6M0.0%$10.46
36
2024-Q4
Increased
325,297
+8.0%
$1.8M0.0%$5.14
19
2024-Q3
New
301,138
-
$1.9M0.0%$6.18
40

Other major holders of NVCT: BlackRock, Inc., VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used